The AMA is collaborating with recognized disease experts, national data providers and medical specialty groups to incorporate unique drug therapy information, disease prevalence and practice guidelines into an educational delivery format. The prescribing data included in AMA Therapeutic Insights are provided by IMS Health. The data are fully compliant with federal privacy standards and do not contain any patient identifiable information.Click here to read the press release. Click here to access AMA Therapeutic Insights.
Physicians interested in continuing medical education can access AMA Therapeutic Insights to earn AMA PRA Category 1 Credit(TM) that can be applied toward the Physician Recognition Award (PRA).
Tuesday, May 22, 2007
AMA Therapeutic Insights released (eCME activity)
From the PRNewswire press release: